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Extracellular vesicles (EVs) have recently emerged as intercellular conveyors of biological information
and disease biomarkers. Identification and characterization of RNA species in single EVs are currently
challenging. Molecular beacons (MBs) represent an attractive means for detecting specific RNA
molecules. Coupling the MBs to cell-penetrating peptides (CPPs) provides a fast, effective, and mem-
brane-type agnostic means to deliverMBs across the plasmamembrane and into the cytosol. Here, we
generated RBCs-derived EVs by complement activation and tested the ability of MBs coupled with
CPP to detect miRNAs from RBC-EVs. Our results showed that RBC and RBC-EVs miRNA-451a can
be detected using MB-CPP, and the respective fluorescence levels can be measured by nano-flow cy-
tometry. MB-based detection of RNA via nano-flow cytometry creates a powerful new analytical
framework in which a simple addition of a reagent allows profiling of specific RNA species present
within certain EV subsets.
INTRODUCTION
A novel paradigm in paracrine signaling has recently emerged based on the findings identifying extracel-
lular vesicles (EVs) as multifaceted, intercellular conveyors of biological information (Tkach and Thery, 2016;
Thery, 2015). EVs and their cargo have been shown to regulate gene expression and alter cell function in
various cell types (Kreimer et al., 2015; Mantel et al., 2013). Isolation and molecular profiling of subsets
of EVs (i.e., RNAs, proteins, lipids, metabolites) are critical for understanding the biogenesis of EVs and
their potential utility as biomarkers. Simultaneous, multiparametric characterization of external protein
and internal RNA components of single EVs is currently challenging owing to the limitations of currently
available EV analysis assays. These require bulk analyses, thus limiting the detection of low abundant EV
components and detection of EV DNA/RNA/proteins, and involves time-consuming (RNA-seq, dd/q-RT-
PCR, southern/northern/western blot), as well as expensive (-omics) analyses.
Using the EV RNA cargo as an indicator of tissue origin or disease marker relies on identifying and quan-
tifying the expression level of various RNA species from isolated EVs. When analyzing EV populations for
low copy number of RNAs, it is easy to underappreciate rare signal, which may contain critical information
about incipient processes in the host, as the information obtained represents an average and does not ac-
count for EV heterogeneity.
Molecular beacons (MBs) are hairpin-shaped oligonucleotides that contain a complementary sequence to
a specific RNA or ssDNA molecule, a fluorochrome, and a quencher (Giesendorf et al., 1998; Tyagi and
Kramer, 1996). Upon binding to target, MB undergoes a conformation change that separates the quencher
from the fluorochrome, thus allowing the probe to fluoresce upon excitation. We have shown that the bind-
ing between the DNA/RNA target and MB is highly specific, with even one pair mismatch anywhere on the
sequence preventing the opening of the stem and thus keeping the MB non-fluorescent (Bonnet et al.,
1999; Marras et al., 1999; Tyagi et al., 1998). Most if not all extracellular and intracellular RNA species are
bound to various RNA-binding proteins, interactions that could potentially interfere with the MB-based
detection approach. Since the binding affinities of oligonucleotide probes to their targets are at least an
order of magnitude higher than the binding affinities of RNA-binding proteins to their targets, MBs are suc-
cessfully able to bind to mRNAs in living cells by displacing the bound proteins (Bratu et al., 2003; Chen
et al., 2017b; Vargas et al., 2005).
Cell-penetrating peptides (CPPs) are short peptide sequences, rich in lysine or arginine, that have the abil-
ity to cross biological membranes through either passive or active processes. Based on their overall charge,iScience 23, 100782, January 24, 2020 ª 2019 The Author(s).
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CPPs belong to three distinct classes: cationic, amphipathic, and hydrophobic, each of which use a distinct
mechanism for membrane fusion and internalization, although the precise molecular mechanisms are still
poorly understood (Vives et al., 2003). As CPPs can be coupled to a wide range of biological compounds,
they represent an attractive delivery vehicle perfectly suited to bridge the gap between specific RNA detec-
tion, imaging- and flow-friendly readouts, and simplicity of use. CPPs coupled to MBs have been used for
tracking mRNA in living cells successfully before (Nitin et al., 2004).
We herein describe a novel method for interrogating the RNA content of circulating EVs, which combines
the sensitivity and specificity of MBs to provide specific RNA information with the high throughput of nano-
flow cytometry (nFC) for detection of specific RNA molecules in subsets of EVs. Our results show that inter-
rogating cells and EVs with MBs coupled to CPPs provides fast and reliable results, which are fully consis-
tent with more sophisticated, and time consuming, RNA detection methods such as q-RT-PCR.
RESULTS
Extracellular Vesicles Contain Unequal Amount of RNA
Imaging and tracking small RNA molecules in cells, without the use of involved methods such as microin-
jection of labeled RNA molecules or RNA in situ hybridization, is complicated by the lack of exclusive RNA
dyes, the presence of large amounts DNA in nucleus and mitochondria (13 kb), and the existence of
significant levels of m, r, and t RNAs in cytosol. Red blood cells, by lacking organelles, DNA, and mRNA
molecules, offer a significant advantage for studying EV biogenesis (originating from plasma membrane,
i.e., microparticles) and RNA loading into EVs. We and others have shown that circulating RBCs contain
few species and copies of small non-coding RNAs (sRNAs) relevant in host pathogen interaction (LaMonte
et al., 2012; Mantel et al., 2016), and reviewed by Walzer et al. (Walzer and Chi, 2017). Using Syto9, a mem-
brane-permeable RNA selective dye (Figure 1A, left panel, arrows), the RNA content of RBCs can be suc-
cessfully labeled and tracked as it is packaged into EVs. Importantly, the RNA content of circulating RBCs
decreases with the age of the cells, with newly released RBCs from bone marrow containing the largest
amount of sRNAs (Figure 1A, middle panel, reticulocytes), whereas the older, smaller RBCs having virtually
non-detectable sRNAs by fluorescence microscopy (Figure 1A, right panel, old RBC). A similar trend was
observed when new, intermediate, and old RBCs were isolated from three independent donors using Per-
coll gradient and total RNAwas quantified by fluorometry (Qubit, Thermo Fisher) (Figure 1B). Next, we took
advantage of the uncluttered RNA landscape of human RBCs to quantify the range of sRNAs present in
complement-generated EVs following our validated protocol (Kuo et al., 2017). The efficacy of comple-
ment-mediated EV generation was verified by transmission electron microscopy (Figure 1C), resistive pulse
sensing (qNano, Izon) (Figure 1D), and nano-flow cytometry (Figure 1E, gate ‘‘EVs’’). Next, the total RNA in
RBC-EVs was labeled using Syto9 as show above. Our results show that even if the EVs were generated from
the same cell type (RBCs) using the same method (complement activation, Figure 1F), their RNA content
was not uniformly distributed among EVs (Figure 1G). Although virtually all EVs contain some amounts
of sRNAs (Figure 1G, see the sub-log, unimodal shift of the main EV population), a subpopulation of EVs
contained larger (over a log fluorescence difference) amounts, and presumably different types or se-
quences of sRNA (Figure 1G, arrow). Therefore, we investigated the effectiveness of MBs to label only
EVs containing specific miRNA sequence, thus bypassing the need for EV isolation and purification as
well as RNA-seq or qPCR.
Detection of miRNA by MBs Using Fluorometry and Nano-Flow Cytometry
Current detection of specific miRNAs species is performed using RNA-seq or targeted qPCR-based ap-
proaches, which implies the use of involved and time-consuming procedures. MBs offer a one-step direct
approach based on direct hybridization of the probe to the target nucleic acid sequence. We tested the
ability of bead-attached MBs and CPP-coupled MB to identify the presence of specific miRNAs in buffer
by incubating increasing concentrations of target or scrambled control miRNAs with complementary
MBs immobilized on 10-mm sepharose beads (Figures S1 and S2). Our results, consistent with previous re-
ports (Mhlanga and Tyagi, 2006; Nitin et al., 2004; Tyagi and Kramer, 1996), show a direct relationship be-
tween the concentration of the target miRNAs and fluorescence of the MBs attached to streptavidin-se-
pharose beads. The lowest concentration of miRNas immobilized on beads that generated a significant
fluorescence signal (MFI 6.22) over the control scramble miRNAs (MFI 4.01) was 5 nM. Each streptavidin-
sepharose bead would immobilize between 5,000 and 12,000 MBs, explaining the large fluorescence shift
observed with higher concentrations of miRNAs. However, it is unlikely that such large numbers of the same
miRNA species are present in any given EV or EV subpopulation. Thus, we tested the ability of our approach2 iScience 23, 100782, January 24, 2020
Figure 1. EVs from the Same Cell Type Have Uneven RNA Loading
(A) Human RBC labeled for sRNA showing circulating age-related loss of cell sRNA (top row).
(B) Correlation plot of the total RNA content of old, intermediate, and new RBCs from three independent donors.
(C) Electron micrograph of an EV budding from RBC plasma membrane showing lack of or minimal amounts of hemoglobin content compared with the
concentration of cytoplasmic hemoglobin of the parent cell.
(D) RBC-EVs diameters were measured using resistive pulse sensing (qNano).
(E–G) (E). Nano-flow cytometry of RBC-derived EVs in the presence of buffer (F) or 5 nM Syto9 (G), showing uneven RNA staining in EV population.to detect physiologically relevant concentrations of miRNA using platelets and RBCs, two of the most
abundant cell types in the blood and major contributors to circulating EVs.
Membrane-Penetrating Peptides Effectively Deliver Cargo to Cells and Extracellular Vesicles
We started by testing the efficacy of fluorescently labeled cell-perpetrating peptides, based on TAT
sequence (CPP-FAM) to cross the plasma membrane and label circulating cells. We incubated freshlyiScience 23, 100782, January 24, 2020 3
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Figure 2. CPPs Effectively Deliver Cargo to Cells and EVs
(A) Buffy coat cells were incubated with CPP-FAM, washed, and imaged using an Olympus BX62 microscope or quantified
using a BD LSR II flow cytometer (BD Biosciences, NJ, USA). The respective histograms show autofluorescence (red) and
penetration by CPP-FAM (blue).
(B) Dot-plot profile of RBCs.
(C) Penetration of RBC-membrane by CPP-FAM.
(D) Dot-plot profile of plasma EVs (arrow).
(E) Penetration of EV membrane by CPP-FAM (blue histogram). Incubation of EVs-CPP-FAM with 0.2% trypan blue does
not decrease the fluorescence signal compared to buffer-treated sample (red histogram, behind the blue). Orange
histogram represents the autofluorescence of EVs. Experiments performed four times.isolated buffy coat cells with 20 mM CPP-FAM for 20 min at RT without mixing (Figures 2A–2C). Our results
show that, although all the circulating cells tested were labeled by CPP-FAM, the intensity of the signal var-
ied significantly with the cell type. Platelets, lymphocytes, and PMNs had the lowest signals (MFI 964, 1,800,
and 3,645, respectively) and RBCs andmonocytes the highest (MFI 9,803 and 18,710, respectively). The vari-
ation was likely due to differences in the cell volume, internal pH, and, possibly, membrane composition.
For lymphocytes, a subpopulation of 14.1% had a higher CPP-FAM uptake than the remaining 85.9%. We
next tested (Figures 2D and 2E) the penetrating capabilities of CPP-FAM on EVs by incubating cell-free
plasma with a diluted solution of CPP-FAM for 20 min at RT, following our published protocols (Danielson
et al., 2016; Shah et al., 2017) with 2 ng/mL CPP-FAM. After 20 min, the mixture was analyzed, without
washing, by nano-flow cytometry. Our data show a unimodal shift of the EV fluorescence following CPP-
FAM treatment (Figure 2E, blue histogram, versus plasma control, orange), strongly suggesting that
CPP-cargo penetrates all plasma EVs, without bias for a certain membrane type or cell origin. An alternative
explanation could be that a population of CPP-FAM became attached to the outer leaflet of all circulating
EVs, as it is commonly seen in cells pretreated with CPP-FAM (Illien et al., 2016). We investigated this alter-
native explanation by using FAM as the fluorophore bright as it is quenchable by trypan blue treatment.
Thus, we tested whether the FAM fluorescence was originating from within the EVs, was associated with
the plasma membrane, or both by incubating an aliquot of the EVs-CPP-FAM mixture with 0.2% trypan
blue for 5 min. Our results showed that the fluorescence intensity did not change measurably following try-
pan blue-mediated quenching (Figure 2E red histogram behind the blue), strongly indicating that CPP-
FAM complexes were in fact inside the EVs and therefore not quenchable in the trypan blue. While the
signal associated with CPP-FAM depends almost exclusively on the amount of probe trapped by each
EV, and thus by the EV volume, the signal intensity for a specific miRNA-CPP-FAM depends on the number
or RNA targets when detecting specific RNA molecules by molecular beacons could be significantly lower.
Detection of Cell-Specific EV miRNAs by CPP-MBs
We designed a CPP-miRNA-MB against miR-495, an miRNA enriched in circulating platelets and also rele-
vant in the pathogenesis of a number of cancers (Chen et al., 2017a; Li et al., 2016). Our results in Figure 3A
show that incubation of whole blood with CPP-miR495-MB for 5 min at RT resulted in specific and strong
labeling of the platelet population without any detectable labeling of the red blood cells or nucleated cells,
even after 30 min of imaging. The CPP-miR495-MB labeling of the platelets (arrows in Figure 3A1) was both
diffusely distributed throughout the cytoplasm and compartmentalized in vesicle-like structures, possibly
primary- or alpha-granules (inset in Figure 3A1, upper left panel). Other circulating cells present in the
blood, such as RBCs, seen as concave shadows, and PMNs, outlined in Figure 3A2–4, did not display
any detectable signal in the cytoplasm. However, overnight incubation of whole blood with MBs showed
discreet punctuated fluorescent pattern in circulating neutrophils, possibly in the lysosomal compartment.
We next tested the efficacy of CPP-MBs to label platelet-specific EVs by imaging cell-free plasma incubated
with CPP-miR495-MB using double-immersion, high-resolution dark field imaging (Figure 3B) achieved by
immersion of both the high-numerical aperture (NA) cardioid-type condenser (NA = 1.4) and the 100x1.35
PlanApo objective fitted with iris diaphragm, coupled to fluorescence microscopy (Figure 3C) or by nano-
flow cytometry (Figure 3D and 3E). Although dark-field microscopy has the advantage of identifying smaller
particles with sizes down to 20–40 nm (Craig et al., 2010), it cannot differentiate between EVs and other par-
ticles such as lipoprotein complexes and protein aggregates within the same size range. The lack of regis-
tration between the dark-field and the fluorescence signals (arrows in Figures 3B and 3C) was likely due to
(1) the Brownian motion of certain EVs, (2) the short exposure time required for dark-field images, and (3)
the relatively long exposure times (tens to hundreds of milliseconds) for the fluorescence acquisition. When
using fluorescence microscopy, the percent positive populations for CPP-miR495-MBs varied between 3%
and 8%, depending on the donor. Analyzing the same specimen by nano-flow cytometry using miR495-MBiScience 23, 100782, January 24, 2020 5
Figure 3. Detection of EV miR-495 by Molecular Beacons
(A) Detection of platelet-associated miR-495 by fluorescence microscopy (arrows).
(B–E) (B) Detection of EV by dark-field microscopy and (C) miR-495-specific signal by fluorescence microscopy (arrows). Nano-flow cytometric profile of
plasma EVs probed with either MB-miR-495 (D) or MB-miR495 coupled to cell penetrating peptide (E). Experiments performed three times, with similar
results.without the cell penetrating peptide as negative control identified a CPP-miR495-MB-positive population
between 13% and 18%, again depending on the donor (Figures 3D and 3E). One explanation for the lack of
correlation between the two measurements could be attributed to the increased detection of EV and non-
EV particles when using dark-field microscopy compared with nano-flow cytometry. Our results indicate
that these combined methods allow an approximate characterization of the MB-generated signal and
the percent of positive nanometer-sized structures.
The RBC miRNA451 Expression Levels Are Variable among Donors
Human RBCs contain several miRNA species, some of which were described to be relevant in malaria path-
ogenesis as well as certain inflammatory conditions (Babatunde et al., 2018; Mantel et al., 2013). We tested
the ability of CPP-MB to detect the amount of miRNAs in human RBCs and RBC-derived EVs using fluores-
cence microscopy, flow cytometry, and dark-field microscopy. Incubation of RBCs with 2 mg of CPP-MB
miR451a RBCs for 1 h at 37C, followed by labeling of the RBCs with a membrane stain (CellMask green)
generated a distinct punctuated pattern in RBCs cytoplasm with some RBCs showing significantly higher
levels of RBC miR451a than others, likely due to differences in the circulatory age of RBCs, similar with
the total RNA staining. Figure 4A also shows that the vast majority of the signal originated from under
the plasma membrane, suggesting that the MB could not penetrate deeper into the RBC, lack of miRNAs
in areas away from the plasma membrane, or an inhibitory effect of hemoglobin on the fluorochromes. We
next used real-time super-resolution microscopy (SRRF), a method that uses a combination of temporal
fluctuation analysis and localization microscopy. This is a relatively recent (2016) (Culley et al., 2018)
super-resolution method, which unlike classical super-resolution imaging methods that require use of
laser-based illumination, extended acquisition and processing times, involved samples preparation, and
dedicated fluorochromes, allows acquisition of super-resolution imaging of standard fluorescence samples
in seconds. Our results show the same RBC imaged either with standard fluorescence microscopy (FL) or
SRRF (Figure 4, upper panel). SRRF clearly identifies discreet MB signals including a miR451a MB located
inside the cytoplasm, as well as an EV-like structure (arrows in insert), suggesting that super-resolution6 iScience 23, 100782, January 24, 2020
Figure 4. Imaging MB Staining with Super Resolution Microscopy, and Detection of EV miR451a by Molecular
Beacon
Top. Increase spatial resolution of actin filaments when imaged by SRRF compared with standard fluorescence.
Bottom. (A) RBC labeled with membrane dye (CellMask, green) and CPP-MB-miR451a-Alexa 594 (red) was imaged
sequentially with standard fluorescence microscopy (FL, left) followed by SR microscopy (SRRF, right). Inset arrow shows
MB signal originating from an EV-like membrane structure located near plasma membrane (arrows). Detection of total
EVs by high-resolution dark-field microscopy (arrows).
(B) Detection of EV miR451a-specific signal by fluorescence microscopy (arrows).
(C and D) (C) Nano-flow profile of plasma EVs probed with either non-penetrating MB-miR451a (C) or membrane-
penetrating CPP-MB-miR451a shows a 30% positive EVs (D). Experiments performed three times, with similar results.
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microscopy permits better quantification and localization of signals originating from MBs than standard
fluorescence microscopy. Somehow unexpectedly, co-staining of RBC RNA with Syto9, a pan-RNA probe,
and CPP MB-miR451a showed limited, if any, co-localization between miRNA451 and the Syto-9 labeled
small RNA, likely, t and rRNAs (data not shown). Similar to the results obtained when investigating
platelet-derived EVs by dark-field microscopy, fluorescence, and nano-flow cytometry, interrogation of
RBC-derived EVs (see Figure 4A and B) rendered similar results with approximately 30% of the total circu-
lating EVs being positive for red-cell-specific miRNA-451 (Figure 4C and D).
Validation of MB-Based Signal by qRT-PCR
We next performed qPCR analysis of miR451a using increasing numbers of RBCs from five unique donors.
Although the standard curve showed as expected, a linear increase in the miR signal with the number of
cells used for RNA extraction (from 103 to 108R > 0.94), our results also indicate that the amount of
miR451a/RBC was significantly different among donors. Our analyses (Figures 5A and 5B), which were per-
formed three times over a period of 8 weeks, showed that certain individuals consistently expressed higher
number of miR451a copies/RBC (average Ct 13/10
8RBCs), or fewer copies of miR451a (average Ct 22/
108RBCs). However, in several donors, the levels of RBC miR451a changed significantly, possibly due to
changes in the proportion of circulating, new RBCs, which contain higher amounts of RNA compared
with the older RBCs (see Figure 1B). We also noted that the detection of the RBC RNA when using fewer
than 10,000 RBCs becomes unreliable (Ct values above 35).
A similar high/low expression pattern was noted in the expression levels of miR451a in circulating RBCs
when using MBs and flow cytometry, with certain healthy donors displaying higher levels of miR451a
(MFI = 72), compared with low expressers, MFI of 44 on average (see Figures 5C and 5D). Next, we
measured the expression levels of RBC miR451a by flow cytometry in seven healthy donors, by incubating
CPP-MB-miR451a with parent RBCs or complement-generated EVs. Most complement-generated EVs
contained detectable amounts of miR451a, and overall the levels of miR451a in EVs, as detected by
CPP-MB miR451a, matched those of parent RBCs (Figure 5E). Specifically, high miR451a RBCs expressers
(MFImiR451a RBC = 37.0) released EVs with high miR451a signal, MFImiR451a EVs = 113.4, whereas low miR451a
RBCs expressers MFImiR451a RBC = 18.0, generated EVs with lower fluorescence signal MFI miR451a EV = 52.7.
These findings would suggest that, at least in the case of RBCs and miR451a, the expression-level profile of
the parent cells is mirrored in EVs. The fluorescence values generated byMBs in EVs were higher than those
measured in parent RBCs probed with the same MBs, probably due to the inhibitory effect of hemoglobin
on beacon fluorescence. The electron microscopy analysis of RBC-EVs show low to no detectable levels of
hemoglobin in RBCs, which may explain the higher MB fluorescence of EVs compared with that of the
parent cell.
We next contrasted the data obtained when using flow cytometry and CPP-MBs by comparing the flow cy-
tometry results with the gold standard method for detecting miRNA gene expression levels, quantitative
PCR. We collected blood from five self-declared healthy donors and measured the expression levels of
miR451a in RBCs and RBC-EVs by qPCR. Our results showed no correlation (R = 0.16, data not shown) be-
tween the levels of miR451a isolated from RBCs and RBC-EVs collected from low, intermediate, and high
miR451a expressers measured by quantitative PCR, even when accounting for the number of RBC-EVs used
for RNA quantification, measured by time-gated nano-flow cytometry (Figures 5F and S3).
Taken together, our results suggest that, even if there is little agreement between the two EV miRNA quan-
tification approaches, using the one-step MB-based detection method and flow cytometry could provide a
rapid, qualitative process for EV RNA detection. This approach is currently limited by the detection of weak
fluorescence in rapid flow conditions, although new instruments are being developed using significantly
slower flow rate to address this very issue (Morales-Kastresana et al., 2019).
DISCUSSION
Characterizing EV RNA profiles is a difficult task owing tomethodological impediments during the EV isola-
tion and purification steps, which are further amplified by convoluted extraction protocols of already low
quantities of RNAs present in EVs, as well as the involved biocomputational analyses of the RNA data. In
addition, most EV isolation protocols rely on the assumption that the expression levels of the certain
RNA targets present in tissue-specific EVs are abundant enough to stand out against the background noise
generated by the RNA present in the rest of the EVs. Our data shown in Figure 1 indicate that, even from8 iScience 23, 100782, January 24, 2020
Figure 5. qPCR Corroborates Molecular Beacon-Based Flow Cytometric Data
RNA from 108 to 103 RBCs was extracted from five donors, and hsa-miR451a was analyzed by qPCR. Heatmap showing all Ct levels from all samples were
clustered showing miRNA-451 levels from high- and low-expression donors (A). Standard curves were generated showing a linear relationship between
miRNA Ct levels and the final amount of RBC (B). Flow cytometry data showed higher geometric MFI for higher-expression-level donor compared with low-
expression donor (C and D). Nano-flow cytometry showed the correlation between miR451a from parent RBCs and complement-generated EVs (E). Nano-
flow cytometry was used to estimate the concentration of RBC-derived EVs obtained from high and low miR-451a expression donors (F).homogeneous cell types, such as RBCs, generation of EVs using complement activation produces EV pop-
ulations heterogeneous in size and variable in RNA abundance. Therefore, enrichment protocols, even
when using cell-type specific surface markers, may underappreciate or could even miss relevant RNA sig-
nals if their number is low.
Detection and quantification of EVs by flow cytometry has been made possible recently by the advent of
new-generation instruments geared toward detection of small particles both by scatter and fluorescence
signature. To date, detecting flow-based EV surface protein profiles relies either on direct antibody-based
detection or on capturing the EV subsets by specific bead-bound antibodies targeting surface proteins.
Extrapolating these methods to detection of specific RNA molecules is of little use owing to the shielding
effect of the vesicle membranes.iScience 23, 100782, January 24, 2020 9
Currently, there are several methods of introducing molecules into cells when interrogating the cargo with
specific probes: (1) derivatizing the probes with acetoxymethyl (AM) groups; this approach, which in fact is a
functional labeling, depends on the presence and activity of cytosolic esterases and is effective only for car-
gos below 0.6–0.8 kDa; (2) incorporating the probes into liposomes; although liposomes are the most
effective delivery system, their fusion efficacy strictly depends on the physicochemical properties of their
membranes, those of the target membranes, on their size, surface charge, and lipid organization (Bozzuto
and Molinari, 2015). However, this approach was used successfully before as a means to detect RNA EV by
fusing EVs with immobilized lipid nanospheres containing specific MBs; (3) cell/membrane-penetrating
peptides (CPPs). We chose CPPs (based on HIV Tat peptide and PNABio-proprietary sequence), a more
expensive alternative, but fast, highly effective, and, importantly, membrane-type agnostic, as seen in
Figure 1.
MBs represent an attractive alternative for identification of specific RNA molecules owing to their spec-
ificity, ease of use, high signal to noise ratio, and the use of standard fluorochromes, which are easily
detectable by instruments routinely used in virtually all research and clinical laboratories. Therefore, to
overcome the current technological limitation of EV detection and RNA interrogation, we proposed
herein an approach that combines the advantages of analyzing hundreds of thousands to millions of
EVs, allowed by small particle flow cytometry, with the sensitivity and ease of use of RNA detection
permitted by MBs. We next circumvented the inability of standard MBs to cross the EV membranes
by attaching to MB membrane-penetrating peptides, an approach that was used for over 20 years to
introduce small molecules in cells, but never with EVs. Recently, a fluorimeter-based detection method
for MBs in EVs has been reported (Rhee and Jeong, 2017). The method uses Streptolysin O for perme-
abilization of EVs to allow MBs access to the RNA targets. We believe our approach, which does not
rely on creating pores in plasma membrane, thus preventing the putative loss of molecules with MW
under and of 100 kDa, may provide a more accurate representation of the miRNAs EV landscape.
Figures 2 and 3 show that the method presented here can be readily used for the detection of specific
RNA sequences by microscopy, as well as flow cytometers with nanometer resolution. The main disad-
vantage when using microscopy for EV detection is the Brownian motion, which may limit the detection
of weak signals, or generate image artifacts. However, for immobilized EVs, either by using poly-L-lysine
or capture antibodies-coated slides, microcopy offers significantly longer integration times (seconds)
compared with flow cytometry (tens of microseconds) and is therefore better suited at detecting dim
signals. Somehow unexpected, SR imaging the MB-based signal in cells did not reveal more structural
details than regular high-resolution fluorescence microscopy, nor did it provide better quantification of
the signal. It is possible that other super-resolution microscopy techniques with better resolving power
may uncover yet unidentified details regarding the dynamics and behavior of individual miRNAs in cells
and EVs.
If our results regarding the predetermined levels of miRNA451 in human circulating RBCs, obtained from a
very limited number of self-declared healthy donors, can be validated in larger cohorts, it could have sig-
nificant clinical implications. We have recently shown that miRNA451-rich EVs are released by circulating
RBCs during malaria infection and fuse with and trigger a specific response in endothelial cells. Endothelial
cell dysfunction in brain capillaries is a critical step leading to cerebral malaria, a complication with mortal-
ity of over 30%. Although signaling pathways involved several checkpoints and are redundant, these find-
ings may suggest that the miR451a levels present in circulating RBCs could predispose patients with ma-
laria to severe cerebral complication of malaria, and even death. A quick CPP-MB-based test readable by
standard flow cytometry could help triage the patients at risk.
It is also worth noting that the number of cells in the subpopulation of lymphocytes having a larger uptake
of CPP-FAM (14.1%) matches the ratio of B lymphocytes (5%–15%) in blood. This could suggest that B lym-
phocytes are more likely to be penetrated by CPP than T lymphocytes, although further studies would be
needed to show whether this is the case or if this is just a coincidence.
There are several limitations in extrapolating the RNA detection results obtained by flow cytometry to
those generated by qPCR, as we presented them in Figure 5. Although currently flow cytometry still lacks
single EV sensitivity, it allows detection of fluorescence-associated signal for each trigger event, therefore
permitting quantification of the MB-associated signal, which likely originates from several MBs and several
EVs. On the other hand, qPRC has a sensitivity superior to that of flow cytometry-based RNA detection, but10 iScience 23, 100782, January 24, 2020
it is vulnerable to slight variations in EV input. Our results in Figure S3 show that the same method of EV
generation (complement activation), using the same number of RBCs (109), can generate vastly different
numbers of EVs depending on the donor. In addition, the proportion of circulating new RBCs compared
with old (Figures 1A and 1B) would likely generate EVs with different RNA cargo loads (Figure 1G) further
underscoring the need for normalization of the results based on the number of EVs used for analysis.
In summary, we have described a rapid and precise detection method that (1) allows identification of EV
subpopulations based on specific sequences of RNA that is (2) compatible with standard fluorescence mi-
croscopes and nano-flow cytometers, (3) can be used with other MBs or antibodies against protein targets,
for multiplex-RNA/protein type analyses, and (4) can be used for sorting of EV subsets with specific RNA
sequences for further downstream validation and discovery work.Limitation of the Study
The ability of flow cytometers to identify and measure individual EVs is still controversial, and the signal
read by the instrument and assigned to one trigger event may in fact represent an average of signals orig-
inating in many EVs of various fluorescence and size profiles. Similarly, the fluorescence of one MB may be
too weak to be reliably detected by the flow cytometer detector in the limited time (in average 22 ms) af-
forded to signal acquisition during the passage of the EV in front of the interrogation area of the instru-
ment. MB detection limit may be constrained by the low volume of the EV and the steric hindrance of
the MB-target miRNAs creating a negative bias against the actual miRNAs abundance. These suggest
that, unlike fluorometers, which can integrate the MB fluorescence signal over tens of seconds, current
flow cytometers can only detect signals originating from MBs if the fluorescence is bright enough for the
limited dwell time of the signal on the detector. An added complication when detecting specific sRNA fluo-
rescence signal originating from EVs is their reduced size range and limited number of RNA copies per EV.
AlthoughMBs present a novel avenue for detectingmiRNAs inside EVs when paired with CPPs, this method
is still subject to the inherent difficulties common to all MB experiments. Fluorescent intermittency, or
blinking (Lukinavicius and Johnsson, 2014), common in all nanoscale light sources, depends on the power
of light source, the length of exposure, and power-law distribution of the ‘‘on’’ and ‘‘off’’ fluorescence over
time. Systems that have a power-law distribution do not have a characteristic scale, meaning that the state
of the MB cannot be accurately predicted at a given time point. This implies that it is unlikely that repeated
flow cytometric measurements under the same conditions would yield the same fluorescence intensity over
time.METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.SUPPLEMENTAL INFORMATION
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Transparent Methods 
Reagents;  
Antibodies (Abs) were obtained as follows: nonimmune IgG1, (BD Biosciences, San Jose, CA); 
secondary antibodies: AlexaFluor-488 goat anti–mouse IgG, AlexaFluor-594 goat anti–rabbit 
IgG, and AlexaFluor-594 goat anti–mouse IgG (Thermo Fisher Scientific, Waltham, MA); Buffers 
and reagents: PBS, HBSS, HBSS++, Trypan Blue, Syto9, Cell Mask (Thermo Fisher Scientific, 
Waltham, MA). Complement proteins: Human C5b,6 complex, Human C7 protein, Human C8 
protein, Human C9 protein (Complement Technology, Inc. Tyler, TX) 
 
Preparation of RBCs and buffy coat cells 
The current study was approved by the Beth Israel Deaconess Medical Center Institutional 
Review Board (IRB). Two mL of fresh whole blood was obtained via venipuncture using 
Vacutainer EDTA tubes (BD, Franklin Lakes , NJ) from self-declared healthy volunteers. 
Hemoglobin concentration values for each donor were obtained using a hemoglobinometer (Hb 
201+, HemoCue, Ängelholm, Sweden). White cells separated by passing the blood through an 
Acrodisc WBC syringe filter (Pall Corporation, NY, NY), washed twice at room temperature, 
centrifuged twice at 500xg. RBCs were re-suspended in HBSS with calcium and magnesium 
(HBSS++), counted using a slide hemocytometer, and adjusted to concentrations specific for 
each experiment. For testing the CPP-FAM (Fig. 2), buffy coat cells were isolated by allowing 
venipuncture blood to settled at room temperature for 45 minutes, followed by two washes in 
HBSS ++. Cells were then incubated with CPP-FAM for 20 mins and analyzed by flow cytometry. 
 
Separation of new and old RBCs 
Two x109cells in 1.5 mL of  HBSS ++ were loaded on top of 40 mL of self-forming Percoll 
gradient solution (30.76 mL Percoll (density 1.130 g/mL, GE Healthcare Bio-Sciences, Uppsala, 
Sweden), 4 mL 1.5 M NaCl, and 5.24 mL of deionized water) in a 30 mL centrifuge tube.  The 
tubes were centrifuged at 27,000 × g for 20 minutes. At the end of the centrifugation time, 
multiple layers of RBCs of different densities are formed within the tube, with the least dense 
(newest) in the top layer and the most dense (oldest) in the bottom layer. RBCs from the top 
and bottom layers were collected separately, washed twice in HBSS++, resuspended at a 
concentration of 5 × 108 cells/mL, and RNA extracted and quantified as detailed below. 
 
Generation of RBC-EVs by complement activation 
RBCs, (2x109cells in 1.5 mL of HBSS ++) were incubate C5b-6 at a final concentration of 
0.18µg/ml, on a shaker set at minimum, at 37°C. After 15 minutes, C7 was added to the cell 
suspension to a final concentration of 0.2µg/ml, and left on the shaker for and additional 5 
minutes. C8 and C9 were then to a final concentration of 0.2µg/ml, and 0.45µg/ml respectively, 
and complement activation allow to continue for an additional 20 minutes. At the end of the 
incubation time, cells were centrifuged twice at 2.500´g for 10 minutes, and then 12,000xg for 
another 10 mins. The supernatant was loaded on a qEV column (Izon), and fractions 1-4 were 
collected using the AFC (Automatic Fraction Collector, iZon) and pooled into a volume of 2 
milliliters. The resulting EV-containing volume was then concentrated using 10kDa cut-off 
Amicon Ultra-4 filter (Millipore, Burlington, MA) by centrifugation at 4,000xg for 10 minutes.  Two 
hundred microliters of the final 400 uL final volume were then processed for EV RNA extraction 
as detailed below. 
 
Synthesis of MB, CPP-MBs 
All MBs were labeled with a fluorophore reporter dye (FAM, AlexaFluor 488, or AlexaFluor 647) 
at the 5′-end and a BHQ quencher at the 3′-end. All MBs were synthesized by either 
BioSynthesis (Lewisville, TX), or PNABio (Newbury Park, CA) with specific sequences as 
follows:  
MiR-495: 5′-CGCGATCGAAGTGCACCATGTTTGTGATCGCG/BHQ-1//iSp18/-3’-Linker-
CPP(tat peptide)-N-terminal of peptide 
hsa-miR-30d-5p: 5'- rUrGrU rArArA rCrArU rCrCrC rCrGrA rCrUrG rGrArA rG -3' 
hsa-mir-495-3p: 5'- rArArA rCrArA rUrGrG rUrGrc rArCrU rUrCrU rU -3' 
hsa-miR-30d-5p: /56-
FAM/CGCGATCCTTCCAGTCGGGGATGTTTACAGATCGCG/ZEN//iSp18//3Bio/ 
mir-495: /56-FAM/CGCGATCGAAGTGCACCATGTTTGTGATCGCG/ZEN//iSp18//3Bio/ 
hsa-miR451a: 5’A594-E-CTCAGTAATGGTAACG-CVSRRRRRRGGRRRR-Lys(BHQ1)3’ 
hsa-miR451a: 5’A594-E-CTCAGTAATGGTAACG- Lys(BHQ1)3’ 
 
Delivery of MB to EVs 
Delivery of MB into the cells or EVs was assured by the presence of CPPs, either the TAT 
peptide or a low molecular-weight protamine peptide (LMWP). As controls, the same MBs were 
used without the attached CPPs of choice. 
 
Coupling MBs to beads. Biotin-coupled MBs were attached to 6.57 um avidin beads following 
the manufacturer's instructions. Briefly, avidin-coated polystyrene particles (Spherotech, Inc., 
Cat. No. VP-60-5) were washed twice in PBS and coupled with 0.01mM miRNA MB (mir-30d or 
mir-495 biotinylated MB, IDT) already suspended in RNAse-free water in 0.1M PBS and left to 
incubate at room temperature for 1 hour. The beads where then centrifuged and washed in 
1mL 0.1M PBS thrice at 20,000xg, resuspended in 405µL 1X PBS, and kept on ice until 
further use. 
 
Dark field microscopy 
For imaging EVs by dark field microscopy, the standard universal condenser was replaced with 
a double-immersion high NA (1.4) dark field cardioid condenser (Olympus Corporation, Walpole, 
MA). The imaging was performed by double immersion, where both the condenser top lens and 
the 100X1.35 UPlanApo iris diaphragm objective were immersed in immersion oil. The iris 
diaphragm of the objective was closed such that the NA of the objective dropped just below that 
of the condenser, thus generating the dark field. Only slides with optimal thickness (1.1 mm) 
were used for imaging the EVs. This was ensured by imaging the focus spot formed on the 
frosted side of the slide when the cardioid condenser was moved to the max top position. If the 
image showed a dark (out of focus) disk surrounded by bright ring, instead of just a bright spot, 
the slide was considered unsuitable for optimal dark field imaging.  
 
Preparation of Plasma and Isolation of EVs   
Preparation of EVs was performed as described previously. (Danielson et al., 2016) Blood (5 
mL) was obtained either by fingerprick or by percutaneous cubital venipuncture drawn in EDTA 
containing vacutainer (BD Biosciences, Franklin Lakes, NJ). Blood was centrifuged at 500 x g 
for 5 min to obtain plasma, followed by two centrifugations of 5,000 x g for 15 min and 12,000 x 
g for 15 minutes, respectively. Samples were processed in microcentrifuge tubes that showed 
no significant ‘shed’ plastic debris observed in the size range of EVs (USA Scientific, 1415-
2500). The topmost lipid rich layer (1000-1500 µL) was discarded and 10 µL of the plasma was 
diluted to a final dilution of 1:1500 in Phosphate Buffered Saline (PBS; Life Technologies, 
Carlsbad, CA). All samples were analyzed by nanoFACS within 30 minutes post processing, 
and all procedures were performed at room temperature. 
 
Electron Microscopy 
RBCs were lightly fixed with 2.5% glutaraldehyde/2% formaldehyde in 0.1 M cacodylate buffer, 
pH 7.4, pelleted, resuspended in 2% low melting temperature sea plaque agarose (Sea Kem 
LE, Cambrex Bio Science, Rockland ME), cooled on ice to form a hard block of cells, and then 
fixed overnight at 4 degrees C in the same fixative.  The agar block was post-fixed with 2% 
osmium tetroxide, en bloc stained with 2% uranyl acetate, infiltrated with graded alcohols 
followed by propylene oxide, and embedded in LX112 resin.  The resulting resin blocks of 
suspended cells were sectioned on an UltraCut E Ultramicrotome (Leica Microsystems, Inc., 
Buffalo Grove, IL) and placed on formvar and carbon-coated slot grids. Sections were stained 
with 2% uranyl acetate and lead citrate and then photographed using a JEOL 1400 electron 
microscope outfitted with an Orius SC1000 CCD camera (Gatan, Inc. Pleasanton, CA). 
 
Nano Flow cytometry  
The MoFlo Astrios EQ was set up according to the specifications detailed in “Characterization of 
EVs by Flow Cytometry” by Camacho et al. Briefly, quality control was performed according to 
the manufacturer’s specifications using the automated QC and Calibration Beads (Beckman P/N 
B27034). After instrument adjustments have been performed, ApogeeMix (Cat #1493) is 
acquired to create a bead sizing curve and is used as a reference for further alignment 
adjustments with the micrometers to ensure maximum signal/noise ratio and dynamic range. 
Apogee beads are used because they range from 110nm to 1300nm consisting of unlabeled 
beads and fluorescently (525nm) labeled beads for added data assurance. The FSC voltage, 
SSC voltage, and threshold are adjusted to maximize the ApogeeMix signals and these settings 
remain constant during the acquisition of EVs. A raw data file was generated to determine 
instrument noise without sample contribution. In addition, HBSS++ was used to dilute the plasma 
EVs to determine the existence of any additional background. Noise (which is the electronic 
noise attributed the instrument and is termed Dark Noise), events contributed by the 
background of HBSS++ used for dilution of samples, and samples are gated accordingly and 
gates remain constant throughout the experiment. Dark noise is tracked to ensure instrument 
consistency and acts as an internal control. The stop criterion was set for time at 120s. Samples 
are acquired at a rate less than or equal to 10,000 events per second.  
 
Extracellular Vesicle Sizing by qNano 
The nanopores (CPC200, Izon) were stretched to 42-50mm, coated with 10% coating solution 
for 10 minutes, and then rinsed with 2% coating solution for 2 minutes. CPC 200 beads (1:500 
dilution) with 2% coating solution were used to calibrate the machine and used as a reference in 
terms of both sizing and counting. Next, EVs (1:10 dilution) with 2% coating solution were 
analyzed following the manufacture’s instructions. Prior to each run and between, the pores 
were washed twice with PBS. Samples were acquired at a voltage of 0.30V. The current was 
kept below 90-100nA with a noise ≈ 10nA. The applied pressure and vacuum were set at 0 and 
adjusted as necessary, but always kept the same throughout each experiment. When the 
current was stable, we started the data acquisition with 500 events or 10 mins acquisition time 
as end point. 
 
RNA extraction, cDNA synthesis and qPCR from RBCs 
RNA was extracted from isolated and purified RBCs collected from 5 self-declared healthy 
donors using MagMax mirvana total RNA isolation kit (Thermo Fisher, US), following 
manufacturer's instructions. For each donor, the number of RBCs used for RNA extraction 
increased by a factor of 10, from 103 to 108.  RBCs were counted using a hemocytometer. 
Complementary DNA (cDNA) synthesis was performed using TaqMan Advanced miRNA cDNA 
Synthesis Kit (Thermo Fisher, US), and qPCR was performed in triplicate using Hsa-miR451a 
(001105 TaqMan assay ID) and TaqMan Fast Advanced Master Mix (Thermo Fisher, US) in 40 
cycles of run in a 7500 Fast Real-time PCR System (Applied Biosystems, US.. Semi-log 
standard curves were generated by Graphpad prism, and the heatmap using Pheatmap 
package in R. 
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Figure S1. Flow cytometry of miRNA and bead-coupled miRNA-MBs, related to figure 2. A 
5 fold serial dilution of miR451a (stock: 0.1mM) was made and 40 µL of the sample, 25µL 
streptavidin-sepharose (FITC) bead-coupled biotinylated miR451a-MB suspension, and 115µL 
RNAse-free water were sampled on a CytoFlex LX. miR30d was used as the unstained control. 
B525 –FITC channel was used for tracking the fluorescence intensity. 6 seconds of back 
flushing was performed between samples. Gains were set with the FSC at 25, SSC at 10, and 
the FITC channel at 50 with the automatic threshold based on the FSC. Sample flow rate was at 
10µL/min. Abort rate was kept under 0.30% with about 240 events per second average. 10,000 
events were recorded for analysis with stop criterion set at 10,000 events or 600 seconds. 
Geometric FITC mean were obtained from the FlowJo analysis software which is calculated 
from the intensity of the sample exceeds the mean of the unstained control. A clear positive 
correlation between the mean fluorescence intensity of beads carrying the molecular beacon 
with the histogram and dot plot overlay can be observed. 
 
 
 
 
100 101 102 103 104 105
0
1000
2000
3000
4000
[miR451] (nM)
m
iR
49
5-
M
B
 (M
FI
)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure S2. Specificity of molecular beacon coupled CPP for in vitro miR451a detection, 
related to figure 2. Increasing concentrations of targets were used and fluorescence was 
measured using a fluorescence plate reader.  
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Figure S3. Detection of RBC-EVs by nanoFlow cytometry, related to figure 5. RBCs isolated 
and purified from 5 donors were treated with complement as discussed in Methods section, and 
EVs were purified by size exclusion chromatography. Apogee, NIST and HBSS++ buffer were 
used as a standard for gating and sizing purposes, and background noise respectively, (top row). 
Supernatants from buffer-, and complement-treated RBCs were recorded for 4 minutes, and event 
numbers in the EV gate recorded for normalization purposes.   
 
 
 
 
 
 
